過剰な銅曝露と男性の生殖毒性:分子メカニズムと潜在的な介入

Zimo Zhou¹, Beiyao Wang¹, Huidan Deng^1,2

¹College of Veterinary Medicine, Sichuan Agricultural University, Chengdu, 611130, Sichuan, People's Republic of China.

Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine

|September 7, 2025

まとめ

銅を過剰に摂取すると精子や丸に損傷を与え男性の生殖能力が損なわれます研究は酸化ストレスなどのメカニズムと抗酸化剤などの潜在的な治療法を探索しています銅による生殖毒性に対抗するためです

科学分野:

環境毒理学
生殖生物学
男性の生殖健康

背景:

銅 (Cu) は不可欠ですが,主に産業や農業からの過剰な毒性があります.
銅の過剰摂取は男性の生殖器系に悪影響を及ぼすという懸念が高まっています

研究の目的:

銅による男性の生殖毒性に関する現在の研究をレビューする.
精子の質,アンドロゲン産生,丸機能への影響について詳しく説明します.
分子機構と治療戦略について話し合う

主な方法:

銅の毒性と男性の生殖に関する科学的研究の文献レビュー.
分子経路に焦点を当てた研究の分析:酸化ストレス,アポプトーシス,オートファジー,フェロプトーシス,クプロプトーシス.
抗酸化物質や銅ケラターを含む潜在的な治療的介入の評価

主要な成果:

過剰な銅は精子のパラメータと丸の構造に悪影響を及ぼします.
分子機構には酸化ストレス,プログラム細胞死 (アポプトーシス,オートファジー,フェロプトーシス),および銅特異細胞死 (クプロプトーシス) が含まれる.
抗酸化剤の治療と銅のケラータは銅の毒性の軽減に期待されています

結論:

銅による男性の生殖毒性は重大な健康問題です.
効果的な治療法を開発するには分子メカニズムを理解することが重要です
金属関連不妊症の予防と管理に役立つ研究が進められます

キーワード:

銅クプロプトーシス男性の生殖への毒性酸化ストレス丸の損傷

さらに関連する動画

13:04

Atomic Absorbance Spectroscopy to Measure Intracellular Zinc Pools in Mammalian Cells

Published on: May 16, 2019

38.8K

09:23

Removal of Trace Elements by Cupric Oxide Nanoparticles from Uranium In Situ Recovery Bleed Water and Its Effect on Cell Viability

Published on: June 21, 2015

9.9K

関連する概念動画

01:41

Spermatogenesis

103.3K

Spermatogenesis is the process by which haploid sperm cells are produced in the male testes. It starts with stem cells located close to the outer rim of seminiferous tubules. These spermatogonial stem cells divide asymmetrically to give rise to additional stem cells (meaning that these structures “self-renew”), as well as sperm progenitors, called spermatocytes. Importantly, this method of asymmetric mitotic division maintains a population of spermatogonial stem cells in the male...

103.3K

01:23

Infertility in Males

331

Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...

331

01:20

Disorders of the Male Reproductive System

569

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....

569

02:07

Oogenesis

64.3K

In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...

64.3K

01:26

Toxic Reactions: Overview

1.2K

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...

1.2K

01:25

Mutagenicity and Carcinogenicity

1.4K

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...